secwatch.observer — SEC 8-K summary
======================================

Issuer:     PSYCHEMEDICS CORP (PMDI)
CIK:        0000806517
Form:       8-K
Filed at:   2023-11-27T23:59:59+00:00
Accession:  0001171843-23-007278
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Psychemedics appoints Daniella Mehalik as VP-Finance and Treasurer, principal financial officer
--------------------------------------------------------------------------------

- Daniella Mehalik, age 33, appointed VP-Finance and Treasurer, effective November 27, 2023.
- She will serve as principal financial and accounting officer, reporting to CEO Brian Hullinger.
- Compensation includes a base salary of $205,000; annual bonus target of 25% of base; 2024 bonus guaranteed at 10%.
- Signing bonus of $10,000 subject to conditions; employment is at-will.
- Ms. Mehalik previously served as Controller at NeuBase Therapeutics (NBSE) from 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/806517/000117184323007278/0001171843-23-007278-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/806517/000117184323007278/f8k_112723.htm
  HTML page:      https://secwatch.observer/filing/0001171843-23-007278

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer